Literature DB >> 2984903

Relation between tumour size and plasma prolactin levels in premenopausal patients with breast carcinoma. A preliminary report.

H Olsson, S B Ewers, M Landin-Olsson, J Ranstam.   

Abstract

In thirty-one premenopausal patients with carcinoma of the breast the plasma prolactin was measured after mastectomy. A highly significant correlation between tumour size and plasma prolactin levels (p less than 0.002) was observed after adjustment for age at diagnosis and parity. At the time of the prolactin determination no clinical signs of metastatic disease were evident, suggesting that the prolactin levels were unrelated to the tumour burden.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984903     DOI: 10.3109/02841868509134365

Source DB:  PubMed          Journal:  Acta Radiol Oncol        ISSN: 0349-652X


  1 in total

1.  A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.

Authors:  H Olsson; A Borg; S B Ewers; M Fernö; T Möller; J Ranstam
Journal:  Med Oncol Tumor Pharmacother       Date:  1986
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.